ERBB2 and ovarian cancer: Triple-negative status was not a sufficient prognostic marker for response to Chk1 inhibition as other cell line types such as the HER2 positive SKBr3 breast cancer cell line and SKOV-3 ovarian cancer cell line were among the most sensitive cell lines to growth inhibition by V158411.